Hôpitaux Universitaires de Strasbourg
Hôpitaux Universitaires de Strasbourg
Strasbourg, France6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy | Duchene Muscular Dystrophy | Recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT07856329 | |
| Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality? | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, conversion disorder, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, psychiatric disorder, relapsing-remitting multiple sclerosis, somatoform disorder | Not yet recruiting | Not applicable | 2026-04-22 | NCT07545889 | |
| National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, connective tissue neoplasm, desmoid tumor, fibroma, neoplasm | Active, not recruiting | Not applicable | 2026-03-30 | NCT02867033 | |
| Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing | Drug Resistant Epilepsy, brain disorder, central nervous system disorder, developmental and epileptic encephalopathy, epilepsy, nervous system disorder | Not yet recruiting | Not stated | 2026-02-09 | NCT07396883 | |
| Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 4 | 2025-07-23 | NCT06906549 | |
| Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 4 | 2025-03-12 | NCT02714634 |